Doxycycline Hyclate Tablet
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Jan 12, 2026 · First posted: Jan 12, 2026 · 1 manufacturers, 2 listed presentations
As of Jan 12, 2026, the FDA lists Doxycycline Hyclate Tablet as being discontinued. Of 2 manufacturer presentations, 2 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02) NDC 0378-0167-02 |
Mylan Pharmaceuticals Inc., a Viatris Company | Not specified | Discontinuation of the manufacture of the drug |
| Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-13) NDC 0378-0167-13 |
Mylan Pharmaceuticals Inc., a Viatris Company | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Doxycycline Hyclate Tablet (FDA data as of Jan 12, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Doxycycline Hyclate Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/doxycycline-hyclate-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).